An adjuvant composition comprising QS21, 3D-MPL and an immunostimulatory oligonucleotide.
PK141233AUndetermined Publication Date: 2011-08-30GLAXOSMITHKLINE BIOLOGICALS SA
0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2011-08-30
Abstract
The present invention provides an adjuvant composition comprising QS21, 3D-MPL and an immunostimulatory oligonucleotide which comprises a purine, purine, C, G, pyrimidine, pyrimidine sequence.
Need to check novelty before this filing date? Find Prior Art